Antidiabetic Drugs Flashcards
1st gen sulfonylurea
SE: hypoglycemia, weight gain, disulfiram reaction
HIGHEST POTENTIAL TO CAUSE HYPOGLYCEMIA
Chlorpropamide
Tolbutamide, Tolazamide
2nd gen sulfonylurea
SE: less hypoglycemia, weight gain, cholestatic jaundice
CI IN PATIENTS WITH HEPATIC IMPAIRMENT AND RENAL INSUFFICIENCY
REQUIRES ISLET CELL FUNCTION
Glipizide
Glimepiride, Glyburide/Glibenclamide
Gliclazide
Meglitinide SE: least hypoglycemia, URTI Used in DIABETICS WITH SULFA ALLERGIES Very short DOA (4-8 hrs only) Requires islet cell function
Repaglinide
Nateglinide (least incidence of hypoglycemia and may be used in CKD PATIENTS)
Mitiglinide
Insulin sensitizer
Biguanide
Inhibition of renal and hepatic gluconeogenesis
SE: GI disturbances, weight loss, lactic acidosis, vit. B12 malabsorption
DOC FOR OBESE DIABETICS
Metformin
CI in patients with renal disease, alcoholism, hepatic disease, CHF, or conditions predisposing to tissue anoxia
MOA of thiazolidinediones
Activates PPAR-gamma receptor
Increases glucose uptake in muscle and adipose tissue
Amylin analog Suppressed glucagon release Delays gastric emptying Anorectic effect Administered as SC with insulin
Pramlintide
GLP1 agonist
Produces satiety
SE: hypoglycemia
Administered as SC in combination with metformin or sulfonylurea
Exenatide
Liraglutide
Incretin modulator
DPP4 inhibitor
Administered orally as monotherapy or in combination with metformin
Sitagliptin
Saxagliptin, linagliptin